Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed Glioblastoma.

Mohammed H AhmedIsaias Hernández-VerdinFranck BielleMaïté VerreaultJulie LerondAgusti AlentornMarc SansonAhmed Idbaih

Published in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2022)

CD86 could be used as a potential biomarker for the prognosis of GBM patients treated with immunotherapy; however, additional studies are needed to validate these findings.

Keyphrases

newly diagnosed
nk cells
poor prognosis
long non coding rna